查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611423

智慧切片檢查設備市場：按應用、最終用戶分類 - 2025-2030 年全球預測

Smart Biopsy Devices Market by Application (Breast cancer, Liver cancer, Prostate cancer), End-User (Academic & Research Institutes, Diagnostic & Imaging Centers, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年智慧切片檢查設備市場價值為51.9億美元，預計到2024年將達到54.9億美元，複合年成長率為6.27%，預計到2030年將達到79.5億美元。

智慧切片檢查設備代表了傳統切片檢查程序和數位技術的複雜整合，旨在提高準確性、效率和整體效果。這些設備通常結合影像技術、資料分析和人工智慧來改善診斷決策。對智慧切片檢查設備的需求源於對癌症和其他疾病的早期、準確診斷、促進及時干預和改善患者治療結果的日益成長的需求。其應用涵蓋腫瘤學、皮膚病學和胃腸病學等多個醫學領域，最終用途為醫院、診所和研究機構。

主要市場統計
基準年[2023] 51.9億美元
預測年份 [2024] 54.9億美元
預測年份 [2030] 79.5億美元
複合年成長率（%） 6.27%

智慧切片檢查設備市場受到癌症發病率上升、個人化醫療進步以及醫療保健支出增加等因素的影響。人們對早期疾病檢測技術的認知不斷增強也推動了成長。最新的商機之一是即時資料分析和遠端醫療功能的整合，可以簡化臨床工作流程並增強遠距離診斷能力。為了抓住這些機會，公司正在投資研發，將更具適應性和易於使用的智慧活體組織切片推向市場，確保合規性，並專注於用戶教育以推動採用。

然而，市場成長面臨著設備成本高、醫療保健預算有限以及阻礙創新和採用的監管障礙等挑戰。此外，鑑於醫療資訊的敏感性，資料隱私問題構成了障礙。創新的絕佳機會在於利用人工智慧開發具有成本效益的解決方案，從而實現更準確、侵入性更小的診斷。此外，與醫療保健提供者建立合作夥伴關係並投資培訓計劃可以減少採用障礙。市場競爭激烈，新技術不斷被整合以保持競爭力，同時適應嚴格的監管環境。總體而言，持續創新和策略夥伴關係是釋放這一快速成長的細分市場潛力的關鍵。

市場動態：快速發展的智慧切片檢查設備市場的關鍵市場洞察

供需的動態交互作用正在改變智慧切片檢查設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 傾向微創手術
    • 全球癌症患者數量增加
    • 切片檢查技術的最新進展
  • 市場限制因素
    • 切片檢查手術高成本
  • 市場機會
    • 增加對癌症研究和診斷的投資
    • 產品改進和傳播的協作策略
  • 市場挑戰
    • 穿戴式裝置的普及

波特五力：駕馭智慧切片檢查設備市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解智慧切片檢查設備市場的外部影響

外部宏觀環境因素在塑造智慧切片檢查設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解智慧切片檢查設備市場的競爭格局

對智慧切片檢查設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣智慧切片檢查設備市場供應商的績效評估

FPNV 定位矩陣是評估智慧切片檢查設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃切片檢查設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對智慧切片檢查設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 微創手術趨勢
      • 世界各地的癌症患者數量正在增加。
      • 切片檢查程序的最新進展
    • 抑制因素
      • 切片檢查手術高成本
    • 機會
      • 增加對癌症研究和診斷的投資
      • 產品演進與滲透的聯合策略
    • 任務
      • 穿戴式裝置的普及
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章智慧切片檢查設備市場：依應用分類

  • 乳癌
  • 肝癌
  • 攝護腺癌
  • 皮膚癌

第7章 智慧切片檢查設備市場：依最終使用者分類

  • 學術研究所
  • 診斷/影像診斷中心
  • 醫院

第8章美洲智慧切片檢查設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太智慧切片檢查設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲智慧切片檢查設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CR Bard, Inc.
  • Canon Medical Systems Corporation
  • Cook Group Incorporated
  • CytoGen, Inc.
  • Danaher Corporation
  • Inivata
  • Innomedicus AG
  • Inrad Inc.
  • Interventional Systems
  • Medtronic PLC
  • Olympus Corporation
  • PLANMED OY
  • TSK Laboratory Europe BV
Product Code: MRR-221461476EF5

The Smart Biopsy Devices Market was valued at USD 5.19 billion in 2023, expected to reach USD 5.49 billion in 2024, and is projected to grow at a CAGR of 6.27%, to USD 7.95 billion by 2030.

Smart biopsy devices represent an advanced integration of traditional biopsy procedures with digital technology, aimed at increasing accuracy, efficiency, and overall efficacy. These devices typically incorporate imaging technologies, data analytics, and artificial intelligence to improve diagnostic decision-making. The necessity for smart biopsy devices stems from the growing demand for early and accurate diagnosis of cancer and other diseases, facilitating timely intervention and improving patient outcomes. Their applications extend across various medical fields, including oncology, dermatology, and gastrointestinal studies, with end-use spanning hospitals, clinics, and research institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 5.19 billion
Estimated Year [2024] USD 5.49 billion
Forecast Year [2030] USD 7.95 billion
CAGR (%) 6.27%

The market for smart biopsy devices is influenced by factors such as the rising incidence of cancer, advancements in personalized medicine, and increasing healthcare expenditures. Expanding awareness about early disease detection technologies also fuels growth. Among the latest opportunities are the integration of real-time data analytics and telehealth features that can streamline clinical workflows and enhance remote diagnostics capabilities. To seize these opportunities, companies should invest in R&D to bring more adaptive and user-friendly smart biopsy solutions to market, ensuring regulatory compliance and focusing on user education to drive adoption.

However, market growth faces challenges including high device costs, limited healthcare budgets, and regulatory hurdles that can slow down innovation and adoption. Additionally, data privacy concerns present barriers given the sensitive nature of medical information involved. The best opportunities for innovation lie in developing cost-effective solutions that leverage AI to deliver more precise, less invasive diagnostics. Furthermore, establishing collaborations with healthcare providers and investing in training programs can alleviate adoption barriers. The nature of the market is highly competitive, with a continuous push toward integrating new technologies to maintain a competitive edge while also navigating stringent regulatory landscapes. Overall, continuous innovation and strategic partnerships are key to unlocking potential in this burgeoning market segment.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Biopsy Devices Market

The Smart Biopsy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Inclination towards minimally invasive surgical procedures
    • Rising number of cancer cases worldwide
    • Recent advancements in the biopsy procedures
  • Market Restraints
    • High cost of biopsy procedures
  • Market Opportunities
    • Rising investment for cancer research and diagnosis
    • Collaborative strategies for product advancements and penetration
  • Market Challenges
    • Penetration of wearable devices

Porter's Five Forces: A Strategic Tool for Navigating the Smart Biopsy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Biopsy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Biopsy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Biopsy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Biopsy Devices Market

A detailed market share analysis in the Smart Biopsy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Biopsy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Biopsy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Smart Biopsy Devices Market

A strategic analysis of the Smart Biopsy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Smart Biopsy Devices Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Boston Scientific Corporation, C. R. Bard, Inc., Canon Medical Systems Corporation, Cook Group Incorporated, CytoGen, Inc., Danaher Corporation, Inivata, Innomedicus AG, Inrad Inc., Interventional Systems, Medtronic PLC, Olympus Corporation, PLANMED OY, and TSK Laboratory Europe B.V..

Market Segmentation & Coverage

This research report categorizes the Smart Biopsy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Breast cancer, Liver cancer, Prostate cancer, and Skin cancer.
  • Based on End-User, market is studied across Academic & Research Institutes, Diagnostic & Imaging Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Inclination towards minimally invasive surgical procedures
      • 5.1.1.2. Rising number of cancer cases worldwide
      • 5.1.1.3. Recent advancements in the biopsy procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of biopsy procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising investment for cancer research and diagnosis
      • 5.1.3.2. Collaborative strategies for product advancements and penetration
    • 5.1.4. Challenges
      • 5.1.4.1. Penetration of wearable devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Smart Biopsy Devices Market, by Application

  • 6.1. Introduction
  • 6.2. Breast cancer
  • 6.3. Liver cancer
  • 6.4. Prostate cancer
  • 6.5. Skin cancer

7. Smart Biopsy Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Diagnostic & Imaging Centers
  • 7.4. Hospitals

8. Americas Smart Biopsy Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Smart Biopsy Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Smart Biopsy Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson and Company
  • 2. Boston Scientific Corporation
  • 3. C. R. Bard, Inc.
  • 4. Canon Medical Systems Corporation
  • 5. Cook Group Incorporated
  • 6. CytoGen, Inc.
  • 7. Danaher Corporation
  • 8. Inivata
  • 9. Innomedicus AG
  • 10. Inrad Inc.
  • 11. Interventional Systems
  • 12. Medtronic PLC
  • 13. Olympus Corporation
  • 14. PLANMED OY
  • 15. TSK Laboratory Europe B.V.

LIST OF FIGURES

  • FIGURE 1. SMART BIOPSY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. SMART BIOPSY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. SMART BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. SMART BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMART BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMART BIOPSY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY SKIN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMART BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES SMART BIOPSY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM SMART BIOPSY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SMART BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. SMART BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023